Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Dilutive issuance
confidence 95%
filed 2026-10-22
Alpha Modus entered into a Securities Purchase Agreement on October 21, 2026, to sell 6,304,348 shares of Class A common stock at $1.15 per share in a registered direct offering, generating approximately $7.25 million in gross proceeds. The company also agreed to issue placement agent warrants representing 7.0% dilution. This is a classic registered direct offering—a dilutive equity issuance to raise capital, with proceeds earmarked for debt repayment and working capital.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-22
The filing discloses an unregistered sale of 15,000 shares of Series C Convertible Preferred Stock to accredited investors for $15.0 million aggregate proceeds on October 21, 2026, under Item 3.02. The Series C Preferred Stock is convertible into common stock at an initial conversion price of $0.3519 per share, with significant dilutive features including 20% annual dividends payable in common stock, a 300% liquidation preference, and director designation rights. This is a classic private placement of convertible securities that will substantially dilute existing common shareholders upon conversion.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 45%
filed 2026-10-22
The filing discloses that the Company's largest stockholder, Asamitsu Kosugi, intends to surrender 97,413,140 shares (approximately 20% of outstanding common stock) for no consideration. While this is technically a share cancellation rather than a new issuance, it materially affects the capital structure and proportionate ownership interests of remaining shareholders. The event is material to investors as it represents a significant reduction in share count and dilution of ownership stakes. However, the classification is uncertain because this is a voluntary surrender/cancellation by a major shareholder rather than a traditional dilutive issuance by the company itself, and no specific 8-K item type perfectly captures this shareholder-initiated capital reduction.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-10-22
PAVmed's subsidiary Lucid Diagnostics entered into subscription agreements to sell 15,000 shares of Series C Convertible Preferred Stock at $1,000 per share for $15.0 million in gross proceeds, with registration rights for resale of underlying common stock. This is a material dilutive issuance of convertible securities to accredited investors, disclosed under Item 1.01 (Entry into a Material Definitive Agreement) and Item 3.03 (Material Modification to Rights of Security Holders), which would materially affect shareholder equity and voting power upon conversion.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 92%
filed 2026-10-22
EX-99.1
This press release announces an underwritten public offering of 400,000 ADSs (representing 2.4 million common shares) at US$4.65 per ADS, generating US$1.86 million in gross proceeds. The offering dilutes existing shareholders and represents a material capital-raising event for a mineral exploration company. The company explicitly states it will use proceeds for working capital and advancing its Rift Rare Earth Project, and the offering is expected to close on October 23, 2026.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 94%
filed 2026-10-22
Item 1.01
CitroTech entered into an underwriting agreement on October 21, 2026, for a registered public offering of 2,240,000 shares at $2.50 per share, generating approximately $5.6 million in gross proceeds, with a 45-day underwriter option for an additional 336,000 shares. The offering materially dilutes existing shareholders and affects the company's capital structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-22
Item 3.02
The filing discloses multiple unregistered sales of equity securities totaling approximately $3.67 million across Class C, Class E, and Class I common shares issued to the Adviser, Brookfield affiliates, feeder vehicles, and employees during October 2026. These private placements under Section 4(a)(2) and Regulation S/D represent dilutive issuances that would materially affect investor assessment of share ownership and capital structure, particularly given the significant volume and the involvement of the affiliated Adviser and Brookfield entities.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-22
Item 3.02
Blackstone Private Credit Fund completed an unregistered private placement of 726,099 Class I common shares for $17.07 million, exempt under Section 4(a)(2) and Regulation S, diluting existing shareholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-10-22
Item 3.02
CXApp issued 214,072 shares of Common Stock to Avondale Capital, LLC between August 24 and October 21, 2026 under a Pre-Paid Purchase agreement at prices ranging from $1.74 to $4.35 per share, relying on Section 4(a)(2) of the Securities Act for unregistered sales. The company simultaneously entered into a Standstill Agreement with Avondale that restricts but does not eliminate Avondale's ability to exercise pre-paid purchase rights to convert outstanding financing instruments into common stock, with the agreement explicitly contemplating resumption of purchases upon termination that could result in additional share issuances and dilution to existing stockholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-22
Item 3.02
Blackstone Private Equity Strategies Fund L.P. and its feeder fund completed unregistered sales of limited partnership units totaling approximately $545.4 million in aggregate consideration to accredited investors and qualified purchasers under Section 4(a)(2) and Regulation D exemptions. This private placement represents a material capital-raising and dilutive equity issuance event for the funds.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-22
Item 3.02
Blackstone Infrastructure Strategies L.P. and its feeder fund completed unregistered sales of approximately $412.5 million in aggregate consideration of new limited partnership units on October 1, 2026, to accredited investors and qualified purchasers pursuant to Section 4(a)(2) and Regulation D exemptions.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-10-22
Item 8.01
ContextLogic announced plans to conduct a rights offering to existing shareholders, with terms to be described in a registration statement and prospectus and expected closing in late 2026 or Q1 2027.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-22
Item 3.02
Blackstone Multi-Strategy Hedge Fund L.P. sold approximately $106.5 million in unregistered limited partnership units to accredited investors and qualified purchasers on October 1, 2026, under Section 4(a)(2) and Regulation D exemptions.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 88%
filed 2026-10-21
Item 1.01
SecureTech Innovations entered into a Securities Purchase Agreement with Hinterland Partners LLC to issue a convertible promissory note with up to $10,000,000 principal amount for $9,000,000 in purchase price. The note is convertible into common stock at 60% of the lowest traded price during the 15 trading days preceding conversion, creating significant dilution potential to existing shareholders through an unregistered private placement under Section 4(a)(2).
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-21
Item 3.02
Stone Point Credit Income Fund disclosed the unregistered sale of 1,617,083.455 common shares at NAV of $24.7338 for an aggregate offering price of $39,996,618.77, plus an additional 47,707.995 shares for $1,180,000, pursuant to capital drawdown notices under subscription agreements. The sales were exempt from registration under Section 4(a)(2) and Regulation D Rule 506, with investors represented as accredited. This is a classic dilutive issuance of unregistered equity securities to raise capital from existing investors.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-21
Item 3.02
KKR FS Income Trust issued 146,235.262 Class I shares for approximately $4.259 million in an unregistered private offering under Section 4(a)(2) and Regulation D to accredited investors, representing a dilutive equity issuance outside registered channels.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-21
Item 3.02
KKR FS Income Trust Select issued 136,926.789 Class I shares for approximately $3.404 million pursuant to a continuous private offering under Section 4(a)(2) of the Securities Act and Regulation D, relying on accredited investor representations.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-10-21
Item 3.02
In connection with the refinancing, Westrock Coffee issued approximately 2.4 million shares of common stock under Regulation D Rule 506(b) as part of a $40 million repurchase of 2029 convertible notes. This unregistered equity issuance is a material dilutive transaction that affects shareholder ownership and serves as a key financing component of the overall refinancing.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-21
Item 3.02
International Seaways completed an unregistered exchange of 1,624,036 shares of Parent common stock to shareholders holding approximately 50.5% of Bruton Limited in reliance on Section 4(a)(2) exemption. This is a classic dilutive issuance of unregistered equity securities, material to investors as it represents a substantial increase in share count and potential change of control implications given the 50.5% stake acquired.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-21
Item 3.02
AB Private Lending Fund sold 28,277 unregistered Class I common shares of beneficial interest to feeder vehicles on October 1, 2026 for approximately $700,000, relying on Section 4(a)(2) and/or Regulation S exemptions from Securities Act registration.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-10-21
Item 1.01
Alpha Teknova entered into an underwriting agreement on October 20, 2026 for a registered public offering of 8,000,000 shares at $5.00 per share, generating $40 million in gross proceeds, with an additional 1,200,000-share option granted to underwriters. This material registered equity issuance dilutes existing shareholders and raises capital for general corporate purposes including potential debt repayment.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-21
Item 3.02
Stepstone Private Credit Fund LLC completed an unregistered sale of 2,123,951 LLC interests for $54.8 million pursuant to subscription agreements, conducted under Section 4(a)(2), Regulation D, and Regulation S exemptions. This private placement represents a significant capital raise and is materially dilutive to existing investors.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-21
Item 3.02
MSD Investment Corp. issued 6,334,459 shares of common stock for approximately $150 million to existing stockholders pursuant to subscription agreements and capital drawdown notices. The issuance was made under Section 4(a)(2) of the Securities Act and Regulation D, relying on accredited investor representations. This is a classic unregistered equity issuance under Item 3.02, representing a material capital raise that dilutes existing shareholders and affects the company's capitalization structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-21
Item 3.02
Fortress Private Lending Fund sold 592,007 Class I common shares for $14.3 million in aggregate consideration to accredited investors pursuant to Section 4(a)(2) and Regulation D exemptions.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-10-21
Item 3.02
SVAQ issued unregistered equity securities in a private placement exempt under Section 4(a)(2) and Regulation D Rule 506(b), including unsecured notes convertible into equity and warrants with an aggregate purchase price of $2,172,000 plus additional notes and warrants to be issued in connection with the proposed Business Combination, materially dilutive to existing shareholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-10-21
Item 3.02
Item 3.02 discloses the closing of a private placement of warrants to purchase 4,510,000 shares of restricted common stock, issued pursuant to Section 4(a)(2) and Rule 506(d) of Regulation D—an unregistered sale of equity securities. This is a classic dilutive issuance that would materially affect a reasonable investor's assessment of ownership dilution and capital structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-10-21
Item 1.01
Quanome Technologies entered into an At The Market (ATM) Offering Agreement with Maxim Group LLC on October 21, 2026, authorizing the sale of up to $9.75 million in common stock. ATM offerings are unregistered equity issuances that dilute existing shareholders and are a classic signal of capital-raising activity at small- and mid-cap issuers. The filing explicitly discloses the offering price cap, the 3.0% transaction fee structure, and intended use of proceeds for working capital and potential acquisitions, all hallmarks of a dilutive equity issuance under Item 1.01.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-21
Item 3.02
The Company issued 9,962,645 shares of common stock to Evervolt on October 15, 2026, as payment of the third tranche ($30.0 million) of the IP Purchase Price under an intellectual property purchase agreement. The shares were issued without registration under the Securities Act in reliance on Section 4(a)(2), and the issuance is currently deferred due to an Ownership Limitation (4.99% beneficial ownership cap). This is a classic dilutive equity issuance to satisfy a material financial obligation, fitting the definition of a private placement under Item 3.02.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 75%
filed 2026-10-21
EX-99.1
The press release discloses termination of an additional purchase right in a registered direct offering announced October 14, 2026. While the termination itself removes future dilution risk, the underlying event is a registered direct offering of ordinary shares and pre-funded warrants with an $18 million additional purchase option. The core transaction—a direct offering of equity securities—is a dilutive issuance material to investors assessing capital structure and shareholder dilution.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-10-21
The filing discloses entry into a Securities Purchase Agreement on September 25, 2026, for the sale of 9,444 shares of Series A Convertible Preferred Stock at $100 per share ($944,400 aggregate), with conversion rights into common stock at $10 per share. This is an unregistered private placement under Section 4(a)(2) and Regulation D Rule 506(b), representing a dilutive equity issuance to raise capital for operational purposes and refinery development. The concurrent Creto investment of 6,000 shares ($600,000) reinforces the capital-raising nature of the transaction.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-21
Item 1.01
Professional Diversity Network entered into Securities Purchase Agreements to issue 146,713 shares of common stock at $1.704 per share (60% of the prior closing price) for approximately $250,000 in gross proceeds. The unregistered sale relied on Section 4(a)(2) and Regulation D exemptions to accredited investors, representing a dilutive private placement to raise capital.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-21
Item 3.02
The filing discloses an unregistered sale of 106,974.359 shares of common stock at $9.75 per share for an aggregate offering price of $1,043,000, conducted pursuant to subscription agreements and exempt under Section 4(a)(2) and Regulation D. This is a classic private placement of equity securities that dilutes existing shareholders and raises capital for the company.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-10-21
Item 8.01
The Company increased the maximum aggregate offering price under an at-the-market (ATM) sales agreement with Benchmark and StoneX by $950,000 to a total of $6,421,000. This is a dilutive equity issuance under an ATM offering facility, which is a material capital-raising event that increases share dilution and is commonly disclosed under Item 8.01 for ATM program amendments.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 85%
filed 2026-10-21
EX-99.1
The exhibit discloses a previously announced private placement of 862,069 ordinary shares at $0.58 per share for $500,000 under a Securities Purchase Agreement dated June 16, 2026. Although the transaction has not yet closed as of October 21, 2026 due to non-receipt of full payment, the Company's update regarding the pending issuance and the termination threat constitute a material disclosure of dilutive equity issuance activity. This falls squarely within the dilutive_issuance category as an unregistered private placement of equity securities.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-21
Item 3.02
Sky Century Investment issued 4,100,000 unregistered shares of common stock to CEO Nataliia Petranetska in conversion of $205,000 of accrued salary, increasing outstanding shares by approximately 41% from 10.1 million to 14.2 million shares.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-21
Item 3.02
Ares Sports, Media & Entertainment Opportunities LP completed an unregistered private placement of approximately $77.0 million in limited partnership units across multiple classes (Class I, Class A-S, Class A-I, and Class E) to accredited investors and qualified purchasers under Section 4(a)(2) and Regulation D, diluting existing unitholders' ownership interests.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-10-21
Item 3.02
The Fund sold 543,863 Class I common shares for $14.5 million during October 2026 in an unregistered offering exempt under Section 4(a)(2) and Regulation S, materially diluting existing shareholders' ownership percentages.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-21
Item 3.02
Ares Core Infrastructure Fund sold 31.1 million common shares for $768.9 million in aggregate consideration in a private placement exempt from registration under Section 4(a)(2) and Regulation D (Rule 506(b)).
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 85%
filed 2026-10-21
Guardian Metal Resources announced the exercise of warrants resulting in the issuance of 300,000 new ordinary shares at 14 pence per share, raising £42,000 and increasing total issued share capital to 199,097,008 shares. This is a dilutive equity issuance that expands the share count and affects existing shareholders' ownership percentages, meeting the definition of dilutive_issuance under Item 3.02 equivalent disclosure.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 75%
filed 2026-10-21
Prudential announces issuance of 10,916 ordinary shares (5 pence each) to be admitted to trading on the London Stock Exchange in connection with a scrip dividend alternative for the 2026 first interim dividend. While framed as a dividend mechanism, the issuance of new equity shares dilutes existing shareholders and represents a capital-raising event. The scrip dividend facility enabling UK shareholders to participate by receiving shares rather than cash constitutes an unregistered equity issuance material to investor assessment of share count and ownership dilution.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-21
Item 3.02
Barings Private Credit Corp completed an unregistered sale of approximately 1.39 million shares of common stock for $27.8 million pursuant to subscription agreements with investors, exempt under Section 4(a)(2) and Regulation D/S. This private placement materially increases the share count and dilutes existing shareholders' ownership percentages.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 80%
filed 2026-10-20
Item 8.01
Strive closed an underwritten public offering of 7,000,000 shares of 15.00% Series A Perpetual SATS Preferred Stock at $90 per share, raising approximately $630 million in gross proceeds. The new preferred shares have senior liquidation preference and voting rights, materially diluting common equity holders and affecting the company's capital structure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-20
Item 3.02
This Item 3.02 disclosure describes multiple unregistered equity issuances by Conexeu Sciences between September 14 and October 15, 2026, totaling approximately 3.4 million shares and units that exceeded 5% of outstanding shares, triggering mandatory 8-K disclosure. The principal transaction is a $3.999 million private placement of 1,333,333 units (each comprising one share and one warrant) to accredited investors on October 15, 2026, relying on Regulation D Rule 506(b) and Regulation S exemptions. Additional issuances include consultant equity grants and warrant exercises. This is a classic dilutive private placement raising capital through unregistered securities, material to investors assessing ownership dilution and capital structure.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 92%
filed 2026-10-20
EX-99.1
The exhibit announces an upsizing of a non-brokered private placement from 2.2 million to 2.7 million units at CDN $0.45 per unit, generating CDN $1.215 million in gross proceeds. Each unit includes one common share and one warrant exercisable at CDN $0.55 for 36 months. This is a classic dilutive equity issuance that increases share count and warrant overhang, materially affecting existing shareholders' ownership percentage and voting power. The company also granted 450,000 stock options to officers at CDN $0.55 per share, adding further dilution.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-20
Item 1.01
First Tracks Biotherapeutics closed a private placement of 6,106,870 shares of common stock on October 19, 2026, and entered into a registration rights agreement with the investors. This is a classic dilutive equity issuance—an unregistered sale of common stock to private investors with registration rights. The materiality is evident from the substantial share count and the company's obligation to register the shares for resale within 30 days, which signals a significant capital raise and shareholder dilution.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-20
Item 3.02
Surrozen completed the second tranche of a private placement on October 20, 2026, issuing approximately 5.7 million shares of common stock, 2.5 million pre-funded warrants, and 4.1 million Series E common warrants for approximately $95.1 million in gross proceeds. This unregistered equity issuance under Section 4(a)(2) and Regulation D generates substantial dilution to existing shareholders.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-20
Item 3.02
Apollo Debt Solutions BDC sold 469,341 unregistered Class I Common Shares for $11.16 million to feeder vehicles, relying on Section 4(a)(2) and Regulation S exemptions from Securities Act registration. This private placement creates dilution to existing shareholders and raises material capital.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-10-20
Item 3.02
The Company issued 15M common shares to Panther Bridge as consideration for the Securities Exchange Agreement, pursuant to an unregistered private placement relying on Section 4(a)(2) and Regulation D exemptions. The shares are restricted and issued to a single accredited investor.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 93%
filed 2026-10-20
Item 1.01
Pluri Inc. entered into a Securities Purchase Agreement on October 19, 2026, to issue 833,334 common shares at $1.50 per share and warrants to purchase an additional 833,334 shares at $1.65 per share to Chutzpah Holdings LP (beneficially owned by the company's largest shareholder and board chairman) in a private placement funded by a $1.25 million advance payment, issued in reliance on Section 4(a)(2) and Regulation S exemptions from registration.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 85%
filed 2026-10-20
The Company issued 3,000,000 Class B ordinary shares at US$1.30 per share (aggregate value US$3,900,000) to acquire a 4.875% equity interest in a target company. The issuance is unregistered, relying on Regulation S and Section 4(a)(2) exemptions, and results in Mr. Yang's beneficial ownership increasing to approximately 87.9% of voting power. This is a material dilutive equity issuance characteristic of a private placement or acquisition financing.
View raw filing on EDGAR →